106 related articles for article (PubMed ID: 26364412)
1. [Bone density measurements after alendronate therapy?].
Schoppmeyer M
Med Monatsschr Pharm; 2015 May; 38(5):196-7; discussion 197. PubMed ID: 26364412
[No Abstract] [Full Text] [Related]
2. [Alendronate].
Okazaki R
Clin Calcium; 2008 Oct; 18(10):1410-6. PubMed ID: 18830037
[TBL] [Abstract][Full Text] [Related]
3. [Diagnosis, clinical feature and treatment of glucocorticoid-induced osteoporosis in patients with rheumatoid arthritis].
Nakayama H
Nihon Rinsho; 2007 Nov; 65 Suppl 9():499-503. PubMed ID: 18161156
[No Abstract] [Full Text] [Related]
4. [Correlation between studies and general practice].
MMW Fortschr Med; 2006 Nov; 148(46):49. PubMed ID: 17615791
[No Abstract] [Full Text] [Related]
5. [Alendronate treatment of osteoporosis secondary to Duchenne muscular dystrophy].
Palomo Atance E; Ballester Herrera MJ; Márquez de La Plata MA; Medina Cano E; Carmona Vilchez RM
An Pediatr (Barc); 2011 Feb; 74(2):122-5. PubMed ID: 21169073
[TBL] [Abstract][Full Text] [Related]
6. [Effect of alendronate on glucocorticoid-induced osteoporosis].
Zou X; Li Q; Shi C
Zhong Nan Da Xue Xue Bao Yi Xue Ban; 2009 Jun; 34(6):563-5. PubMed ID: 19587443
[TBL] [Abstract][Full Text] [Related]
7. Use of generic alendronate in the treatment of osteoporosis.
National Osteoporosis Foundation of South Africa
S Afr Med J; 2006 Aug; 96(8):696-7. PubMed ID: 17019490
[No Abstract] [Full Text] [Related]
8. [Using parathyroid hormone 1-84 in the treatment of osteoporosis: presentation and comments of main clinical trial].
Cesareo R; Napolitano C; Iozzino M; Romitelli F; Iarussi G; Scona M; De Rosa B
Clin Ter; 2009; 160(4):307-10. PubMed ID: 19795085
[TBL] [Abstract][Full Text] [Related]
9. Generic alendronate in the treatment of osteoporosis.
Kanfer I
S Afr Med J; 2006 Oct; 96(10):1008-10. PubMed ID: 17164925
[No Abstract] [Full Text] [Related]
10. Teriparatide or alendronate in glucocorticoid-induced osteoporosis.
Rossi CM; Di Comite G
N Engl J Med; 2008 Mar; 358(12):1302; author reply 1303-4. PubMed ID: 18354112
[No Abstract] [Full Text] [Related]
11. [Progress for patients with osteoporosis].
MMW Fortschr Med; 2006 May; 148(20):56-7. PubMed ID: 16805195
[No Abstract] [Full Text] [Related]
12. [Cost effective osteoporosis therapy. Alendronate is also immediately available as a generic drug].
MMW Fortschr Med; 2005 Dec; 147(49-50):74-5. PubMed ID: 16401016
[No Abstract] [Full Text] [Related]
13. Anabolic therapy in glucocorticoid-induced osteoporosis.
Sambrook PN
N Engl J Med; 2007 Nov; 357(20):2084-6. PubMed ID: 18003966
[No Abstract] [Full Text] [Related]
14. [Evidence of alendronate treatment for osteoporosis].
Harada A
Nihon Rinsho; 2007 Nov; 65 Suppl 9():337-43. PubMed ID: 18161127
[No Abstract] [Full Text] [Related]
15. [New therapeutic approach in glucocorticoid-induce osteoporosis].
Jakob F; Nitschmann S
Internist (Berl); 2008 Dec; 49(12):1524-5. PubMed ID: 19018505
[No Abstract] [Full Text] [Related]
16. Effect of alendronate on bone mineral density in Puerto Rican males with osteoporosis.
Martinó A; Rosa J; Guzmán J; Ramírez M
P R Health Sci J; 2005 Jun; 24(2):131-5. PubMed ID: 16116930
[TBL] [Abstract][Full Text] [Related]
17. Teriparatide or alendronate in glucocorticoid-induced osteoporosis.
Babb RR
N Engl J Med; 2008 Mar; 358(12):1302-3; author reply 1303-4. PubMed ID: 18357641
[No Abstract] [Full Text] [Related]
18. [Influence on atherosclerosis of improvement of bone mineral density after medication for osteoporosis].
Yamada S; Inaba M; Nishizawa Y
Nihon Rinsho; 2007 Nov; 65 Suppl 9():348-51. PubMed ID: 18161129
[No Abstract] [Full Text] [Related]
19. Bisphosphonates in the treatment of osteoporosis.
Poole KE; Compston JE
BMJ; 2012 May; 344():e3211. PubMed ID: 22619192
[No Abstract] [Full Text] [Related]
20. [Osteodensitometry and duration of treatment in osteoporosis].
Bartl R
Dtsch Med Wochenschr; 2010 Mar; 135(11):534. PubMed ID: 20221972
[No Abstract] [Full Text] [Related]
[Next] [New Search]
